Archive | April, 2013

Are ICDs Useful in Preventing SCD in Children and Adolescents with HCM?

Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in the young. The availability of  implantable cardioverter-defibrillators (ICDs) over the past decade for HCM has demonstrated the potential for sudden death prevention, predominantly in adult patients. In children and adolescents with hypertrophic cardiomyopathy , ICDs terminated life-threatening ventricular tachyarrhythmias, but frequently led […]

Leave a comment Continue Reading →

Does a closure of PFO prevent recurrent ischemic stroke?

  Whether closure of a patent foramen ovale is effective in the prevention of recurrent ischemic stroke in patients who have had a cryptogenic stroke is unknown. Two recently published multicenter studies have demonstrated no significant benefit of closure of a patent foramen ovale over medical therapy alone. Both studies were published in March 2013 […]

Leave a comment Continue Reading →

Carvedilol superior to Metoprolol in treatment of heart failure

In a study published on April 1, 2013 issue of the Journal of the American College of Cardiology, by Dr. Martin Ruwald (University of Rochester Medical Center, New York) and colleagues, comparing carvedilol to metoprolol in treatment of patients with heart failure reported that treatment with carvedilol was associated with a significant reduction in the […]

Leave a comment Continue Reading →